Literature DB >> 29431217

The role of mast cells in autoinflammation.

Hanna Bonnekoh1,2, Jörg Scheffel1,2, Naotomo Kambe3,4, Karoline Krause1,2.   

Abstract

The concept of autoinflammation was proposed to define a new class of immune disorders categorized by self-directed inflammation that is driven via activation of innate immune pathways. Within innate immunity, inflammasomes serve as intracellular signaling platforms to endogenous danger molecules and pathogens. Their key function is the cleavage of pro-interleukin-1β (pro-IL-1β) into its active form to promote inflammation and programmed cell death. A growing number of inflammasome sensors were described, among which NLR family pyrin domain containing 3 (NLRP3) is the best-studied sensor. Besides macrophages, monocytes, and other innate immune cells, mast cells (MCs) were shown to express functional inflammasomes too. Also, MCs are both, a source and target of IL-1β. Here we review the functional relevance and role of MC inflammasomes and MC-derived IL-1β in contributing to the inflammation at the skin, joints, and central nervous system in rare monogenic autoinflammatory conditions and also common inflammatory and degenerative diseases.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autoinflammation; inflammasome; interleukin-1β; mast cell

Mesh:

Substances:

Year:  2018        PMID: 29431217     DOI: 10.1111/imr.12633

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  14 in total

1.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

2.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

Review 3.  Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis.

Authors:  Isabelle Pastor Bandeira; André Eduardo de Almeida Franzoi; Giulia Murillo Wollmann; Washigton Luiz Gomes de Medeiros Junior; Wesley Nogueira Brandão; Jean Pierre Schatzmann Peron; Jefferson Becker; Osvaldo José Moreira Nascimento; Marcus Vinícius Magno Gonçalves
Journal:  Neurol Sci       Date:  2022-07-18       Impact factor: 3.830

4.  In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging.

Authors:  Marius Kröger; Jörg Scheffel; Viktor V Nikolaev; Evgeny A Shirshin; Frank Siebenhaar; Johannes Schleusener; Jürgen Lademann; Marcus Maurer; Maxim E Darvin
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

Review 5.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

6.  Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis.

Authors:  Stephanie Young; Namit Sharma; Jae Hoon Lee; Violeta Chitu; Volker Neumeister; Elisabeth Sohr; E Richard Stanley; Christian M Hedrich; Andrew W B Craig
Journal:  Dis Model Mech       Date:  2019-08-20       Impact factor: 5.758

Review 7.  The innate immune perspective of autoimmune and autoinflammatory conditions.

Authors:  Shirly Frizinsky; Soad Haj-Yahia; Diti Machnes Maayan; Yulia Lifshitz; Ramit Maoz-Segal; Irean Offengenden; Mona Kidon; Nancy Agmon-Levin
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

Review 8.  Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms.

Authors:  Hanna Bonnekoh; Monique Butze; Tilmann Kallinich; Naotomo Kambe; Georgios Kokolakis; Karoline Krause
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

9.  Therapeutic effect of Bacillus Calmette-Guerin polysaccharide nucleic acid on mast cell at the transcriptional level.

Authors:  Siyu Yan; Runqiu Liu; Manyun Mao; Zhaoqian Liu; Wei Zhang; Yi Zhang; Jie Li; Cong Peng; Xiang Chen
Journal:  PeerJ       Date:  2019-08-21       Impact factor: 2.984

Review 10.  Beyond IgE: Alternative Mast Cell Activation Across Different Disease States.

Authors:  David O Lyons; Nicholas A Pullen
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.